Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
0.3565
+0.0211 (6.29%)
At close: May 9, 2025, 4:00 PM
0.3502
-0.0063 (-1.77%)
After-hours: May 9, 2025, 4:41 PM EDT
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $16.58 million as of May 9, 2025. Its market cap has decreased by -82.44% in one year.
Market Cap
16.58M
Enterprise Value
17.42M
1-Year Change
-82.44%
Ranking
Category
Stock Price
$0.36
Market Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.65M to $16.58M, a decrease of -95.26%. That is a compound annual growth rate of -62.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 16.58M | -81.43% |
| Dec 18, 2024 | 89.30M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.16M | 5.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 697.29B |
| Johnson & Johnson | 378.48B |
| UnitedHealth Group | 355.95B |
| AbbVie | 332.73B |
| Novo Nordisk | 301.56B |
| Abbott Laboratories | 233.05B |
| Novartis AG | 220.92B |
| AstraZeneca | 217.30B |